Biomanufacturing is the process of production of commercially important biomolecules by utilizing biological systems for use in medicines, food and beverage processing, and industrial applications. Natural sources such as blood, cultures of microbes, animal cells, or plant cells are often employed to carry out biomanufacturing. Cells used in the production process can also be derived using genetic engineering techniques. Biomanufacturing refers to the method of production of biological products from living cells that are commercially important for use in medicines, food and beverage processing, and industrial applications. It is a form of biotechnology that encompasses the use of biomaterials harvested from natural sources such as microbes, blood, animal cells, or plant cells. These cells or ingredients used in the production are either naturally occurring or are synthesized through genetic engineering. In the field of medicine, several biopharmaceutical products such as vaccines, cytokines, amino acids, growth factors, antibodies, and fusion proteins are all manufactured through bioprocessing and are hence called biomanufactured products. The terms “bioprocessing” and “biomanufacturing” are often used interchangeably, the former representing the technologies and system processes, whereas the latter involves implementing bioprocessing practices to produce commercially important biomaterials and biomolecules for specific applications. One key feature distinguishing a biomanufactured product such as monoclonal antibodies from small molecule drugs such as aspirin is their production process. Biomanufacturing is a highly complex, multi-step procedure requiring much more time and expense than that needed for small molecules.

1. Market Overview 

2. Industry Analysis 

3. Market Dynamics 

4. Competitive Landscape

5. Automation in Biomanufacturing

6. Workflow and Products

7. Medical Application